Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.51B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$411M |
| 3 |
Microsoft
MSFT
|
+$300M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Visa
V
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$254M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$178M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$177M |
| 4 |
Blackstone
BX
|
+$139M |
| 5 |
Exelon
EXC
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.38% |
| 2 | Technology | 11.34% |
| 3 | Miscellaneous | 10.58% |
| 4 | Energy | 8.74% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$788M
| $94K | ﹤0.01% |
8,575
+2,500
| +41% | +$22.5K |
2018 Q3
5 quarters
|
|
3527
Griffon
GFF
$4.22B
| $94K | ﹤0.01% |
4,634
+1,433
| +45% | +$30.1K |
2015 Q4
16 quarters
|
|
|
NVMI
3528
Nova
NVMI
$12.3B
| $94K | ﹤0.01% |
2,475
| – | – |
2019 Q2
2 quarters
|
|
|
CUTR
3529
DELISTED
Cutera, Inc.
CUTR
| $94K | ﹤0.01% |
2,624
+72
| +3% | +$2.43K |
2016 Q2
14 quarters
|
|
|
SILK
3530
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $94K | ﹤0.01% |
2,322
+1,096
| +89% | +$38.4K |
2019 Q2
2 quarters
|
|
3531
Anika Therapeutics
ANIK
$259M
| $93K | ﹤0.01% |
1,801
+429
| +31% | +$24.9K |
2013 Q3
25 quarters
|
|
3532
Gossamer Bio
GOSS
$66.9M
| $93K | ﹤0.01% |
75
+17
| +29% | +$27.4K |
2019 Q1
3 quarters
|
|
|
KE
3533
Kimball Electronics
KE
$679M
| $93K | ﹤0.01% |
5,305
+956
| +22% | +$15.7K |
2015 Q1
19 quarters
|
|
3534
LeMaitre Vascular
LMAT
$1.83B
| $93K | ﹤0.01% |
2,594
-124
| -5% | -$4.28K |
2015 Q2
18 quarters
|
|
|
NVO
3535
PUT
Novo Nordisk
NVO
$165B
| $93K | ﹤0.01% |
+3,200
| New | +$88.6K |
2019 Q4
0 quarters
|
|
3536
Quince Therapeutics
QNCX
$31.2M
| $93K | ﹤0.01% |
+8
| New | +$48.3K |
2019 Q4
0 quarters
|
|
3537
Universal Electronics
UEIC
$71M
| $93K | ﹤0.01% |
1,800
+514
| +40% | +$27.5K |
2013 Q2
26 quarters
|
|
|
YMAB
3538
DELISTED
Y-mAbs Therapeutics
YMAB
| $93K | ﹤0.01% |
2,984
+1,196
| +67% | +$35.4K |
2019 Q2
2 quarters
|
|
|
DERM
3539
DELISTED
Dermira, Inc.
DERM
| $93K | ﹤0.01% |
6,145
+1,869
| +44% | +$16.1K |
2016 Q1
15 quarters
|
|
|
LX
3540
LexinFintech Holdings
LX
$116M
| $92K | ﹤0.01% |
6,617
-29,087
| -81% | -$334K |
2018 Q3
5 quarters
|
|
3541
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$406M
| $92K | ﹤0.01% |
+2,487
| New | +$88.9K |
2019 Q4
0 quarters
|
|
3542
Teekay Tankers
TNK
$3.5B
| $92K | ﹤0.01% |
3,840
+926
| +32% | +$16.9K |
2015 Q4
16 quarters
|
|
|
ONIT
3543
Onity Group
ONIT
$230M
| $92K | ﹤0.01% |
4,473
+352
| +9% | +$8.52K |
2013 Q2
26 quarters
|
|
|
CVET
3544
DELISTED
Covetrus, Inc. Common Stock
CVET
| $92K | ﹤0.01% |
6,979
-3,376
| -33% | -$40.9K |
2019 Q1
3 quarters
|
|
|
MIK
3545
DELISTED
Michaels Stores, Inc
MIK
| $92K | ﹤0.01% |
11,398
+1,803
| +19% | +$15.1K |
2015 Q3
17 quarters
|
|
3546
Cato Corp
CATO
$47.6M
| $91K | ﹤0.01% |
5,276
-674
| -11% | -$12.1K |
2013 Q2
26 quarters
|
|
3547
Origin Bancorp
OBK
$1.62B
| $91K | ﹤0.01% |
2,412
+736
| +44% | +$25.8K |
2019 Q2
2 quarters
|
|
3548
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$33.2M
| $91K | ﹤0.01% |
+3,429
| New | +$85.4K |
2019 Q4
0 quarters
|
|
3549
Vanguard International High Dividend Yield ETF
VYMI
$20.7B
| $91K | ﹤0.01% |
1,430
+865
| +153% | +$53.4K |
2016 Q4
12 quarters
|
|
|
LGTY
3550
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $91K | ﹤0.01% |
6,153
+1,120
| +22% | +$17.6K |
2015 Q4
16 quarters
|
|
Similar funds
Bank of Montreal's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of Montreal held 5,174 positions worth $133B, up 15% from $116B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal deployed $8.58B of net new capital in Q4 2019, opening 425 new positions and adding to 2,835 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 28% a quarter earlier, followed by Technology and Miscellaneous.
On the sell side, the largest reduction was Apollo Global Management, an estimated $254M trimmed.
- Bank of Montreal's largest Q4 2019 buy was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.51B increase.
- Bank of Montreal's biggest Q4 2019 reduction was Apollo Global Management, cutting an estimated $254M.
- Bank of Montreal fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $125M.
- Bank of Montreal's ten largest holdings make up 20% of its $133B portfolio in Q4 2019.
- Bank of Montreal opened 425 new positions and closed 298 in Q4 2019.
- Bank of Montreal's portfolio value rose 15% quarter-over-quarter to $133B.
Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.